the company posted positive outcomes for the P2a how can you come up with this?
@Crowdoc the company hasn’t released the full results because that was always the case. Release 2a, release 2b, release fully unblinded results.
The company is just delivering on their plan, not due to anything untoward. I think it would be more abnormal to release full 2a results while the 2b was ongoing. There’s a lot of examples of companies releasing full results on combo trials only after the end of the trial
Ann: ISLA-101 shows anti-dengue activity in Phase 2a readout, page-186
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.010(6.06%) |
Mkt cap ! $36.59M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.0¢ | 15.0¢ | $139.0K | 882.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13834 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 2104 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| ILA (ASX) Chart |